Table of Content

Consumer Health in Switzerland
Euromonitor International
November 2021

List Of Contents And Tables

CONSUMER HEALTH IN SWITZERLAND
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Moderate positive sales growth a reflection of the COVID-19 situation
Return to work and leisure outside of the home boosts demand for analgesics
Rising popularity of CBD products pushes demand for topical analgesics/anaesthetic
PROSPECTS AND OPPORTUNITIES
COVID-19 set to remain a major influence over category sales
CBD-based products expected to become even more popular
Liberalisation of the retail distribution of OTC analgesics unlikely to be seen
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Moderate sales growth as the impact of COVID-19 recedes and challenges remain
The robust performance in medicated confectionery supports overall sales growth
GSK Consumer Healthcare relies on its wide product selection to lead the category
PROSPECTS AND OPPORTUNITIES
Sales to come under pressure as consumers turn to preventative healthcare
The superior air quality in Switzerland to undermine category growth potential
Competitive landscape unlikely to undergo radical change
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Positive growth recorded in digestive remedies as consumers return to “normal life”
Various changes to lifestyle habits have a diverse impact on category sales
Paediatric digestive remedies a casualty of the shift towards preventative healthcare
PROSPECTS AND OPPORTUNITIES
The return to pre-COVID-19 dietary and lifestyle habits likely to support demand
Digestive remedies to face competition due to the shift towards more natural options
Marketing campaigns likely to focus more on natural aspects of products and brands
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
The reopening of Swiss society strongly supports demand for dermatologicals
Hair loss treatments benefits from more liberal approach to non-essential spending
Major players wits strong international brands remain the leaders in dermatologicals
PROSPECTS AND OPPORTUNITIES
Various factors set to boost demand for dermatologicals during the forecast period
The return to pre-COVID-19 lifestyles likely to support demand for dermatologicals
The rise of CBD-based dermatologicals anticipated, boosting sales growth rates
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Significant base of habitual smokers presents opportunities for strong sales growth
Rising health awareness due to COVID-19 benefits NRT smoking cessation aids
Pressure on OTC sales as many consumers prefer alternative options
PROSPECTS AND OPPORTUNITIES
The challenges of quitting smoking likely to support category sales growth
Alternatives to NRT smoking cessation aids set to continue putting pressure on sales
Traditionally popular products expected to maintain their advantages
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Spike in number of Swiss people experiencing anxiety boosts demand for sleep aids
Milder, gentler OTC sleep aids increasingly preferred to stronger Rx options
Major players benefit from the tendency of consumers to stick to what they know
PROSPECTS AND OPPORTUNITIES
More moderate growth slated for sleep aids as the COVID-19 situation eases
More hectic lifestyles in general set to support sales growth in sleep aids
Shift towards milder sleep aids set to benefit herbal/traditional products
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Partial return to pre-COVID-19 lifestyles supports sales growth in eye care
Standard eye care sees more dynamic growth due to caution about going outside
Stable competitive environment a reflection of general preference for leading brands
PROSPECTS AND OPPORTUNITIES
The ageing of the Swiss population set to support higher demand for eyecare
Return to outdoor activity set to boost demand for allergy eye care
Greater focus on sport and fitness likely to benefit sales of allergy eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Improved availability due to the end of quarantine lockdowns boosts sales
The popularity of keeping first aid kits in cars and in the home supports demand
The return to outdoor sports expected to have a positive impact on wound care sales
PROSPECTS AND OPPORTUNITIES
A stable and moderate performance expected for wound care
Few changes expected to be seen in the competitive environment
Sales of wound care products set to shift towards smaller retail outlets
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Positive sales growth as the focus continues to fall on preventative healthcare
Vitamin C and vitamin D benefit from their reputations for fighting COVID-19
Bayer remains the leading player due to its ownership of various leading brands
PROSPECTS AND OPPORTUNITIES
High per capita consumption, maturity of demand likely to mean moderate growth
Multivitamins set to benefit from the convenience that these products offer
Grocery retailers and e-commerce set to gain ground in the distribution of vitamins
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Moderate positive growth registered as consumers look to boost their immunity
Dietary supplements increasingly faces competition from fortified packaged food
Burgerstein by Antistress AG remains the category’s leading brand
PROSPECTS AND OPPORTUNITIES
Slower growth expected as higher competition from fortified packaged food bites
The ageing of the Swiss population expected to spur growth in dietary supplements
A wider range of positioning likely to be seen as brands diversify their offerings
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Increases seen in the numbers of overweight people during lockdown
Convenient, risk-free products remain the most popular options
Supplement nutrition drinks sees growth as consumers aim to improve their health
PROSPECTS AND OPPORTUNITIES
Return to regular strenuous physical activity set to place limits on sales growth
Rising concerns over obesity and strong desire to be slim to underpin sales
Products that offer convenience slated to be among the big winners
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Positive growth due to shift to more active lifestyles, despite impact of COVID-19
The widening of the consumer base is mirrored in the widening of retail distribution
Marketing campaigns become more common as competition intensifies
PROSPECTS AND OPPORTUNITIES
Newfound interest in sports and fitness due to COVID-19 likely to underpin demand
More segmentation inevitable as the consumer base for sports nutrition expands
Grocery retailers to become more important in the retail distribution of sports nutrition
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Shift towards herbal/traditional products part of the wider health and wellness trend
Herbal/traditional sleep aids a big winner as anxious consumers look for stress relief
Medicated confectionery brands perform well due to the presence of COVID-19
PROSPECTS AND OPPORTUNITIES
Further sales growth expected as consumer awareness continues to rise
The rise to prominence of CBD-based products expected to spur sales growth
Herbal/traditional products to face greater competition from healthy fresh food
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN SWITZERLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Low per capita sales due to the general preference for natural remedies for children
Nappy (diaper) rash treatments and paediatric cough/cold remedies remain popular
Desire to avoid visiting a doctor due to fears of contagion boosts demand
PROSPECTS AND OPPORTUNITIES
A muted forecast period performance expected for paediatric consumer health
Products for which no Rx alternatives exist set to generate the strongest growth
Various background factors to suppress growth rates in paediatric consumer health
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026